Cargando…
Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
Personalised medicine, in which clinical management is individualised to the genotypic and phenotypic data of patients, offers a promising means by which to enhance outcomes in the management of mycobacterial pulmonary infections. In this review, we provide an overview of how personalised medicine a...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624359/ https://www.ncbi.nlm.nih.gov/pubmed/34835346 http://dx.doi.org/10.3390/microorganisms9112220 |